Why BioMarin Shares Are Plunging Today?
Biomarin Pharmaceutical Inc (NASDAQ: BMRN) shares are falling in reaction to positive data from BridgeBio Pharma Inc's (NASDAQ: BBIO) dwarfism drug, heating the competition.
‘Johnson & Johnson Phase 3 A DUE Data Show Investigational Single Tablet Combination Therapy Of Macitentan And Tadalafil Significantly Improves Pulmonary Hemodynamics Versus Monotherapy In Patients With Pulmonary Arterial Hypertension’
https://johnsonandjohnson.gcs-web.com/static-files/3137d414-8b4a-432d-bee1-16af33aa8233
Clene’s Lead Amyotrophic Lateral Sclerosis Shows Improved Function, Slowed Disease Progression
Clene Inc (NASDAQ:CLNN) announced new results showing preserved ALS patient functional score (ALSFRS-R) and delayed time to clinical worsening from the…
Investors Cheer Armata Pharma’s Encouraging Data From Lung Infection Candidate
Armata Pharmaceuticals Inc (NASDAQ:ARMP) announced positive topline results from the completed Phase 1b/2a SWARM-P.a. trial evaluating AP-PA02 for chronic pulmonary Pseudomonas aeruginosa infections in…
BioCardia Outlines Detailed Cell Therapy Data From Heart Failure Study
BioCardia Inc (NASDAQ:BCDA) presented detailed echocardiography data from the roll-in cohort of the Phase 3 CardiAMP Cell Therapy Heart Failure Trial.…
BridgeBio’s Dwarfism Candidate Shows Favorable Height Increase, Safety Profile
BridgeBio Pharma Inc (NASDAQ: BBIO) announced results from PROPEL2 Phase 2 trial of infigratinib in children with achondroplasia, a genetic condition affecting a protein in the body called the fibroblast growth factor receptor.
Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer’s Treatment
The FDA has accepted Eisai Co Ltd (OTC:ESALY) and Biogen Inc’s (NASDAQ:BIIB) supplemental Biologics License Application (sBLA) for Leqembi (lecanemab-irmb) 100 mg/mL injection,…
New Study Evaluates The Use Of Masimo PVi As An Indicator Of Fluid Responsiveness To Guide Goal-Directed Fluid Therapy In Adult Neurosurgical Patients
Researchers Found That Noninvasive, Continuous PVi Was Equally Effective in Guiding Fluid Management As Stroke Volume Variation (SVV), an Invasive Method Requiring an Arterial Line
Masimo (NASDAQ:MASI) today
Why Unicycive Therapeutics Stock Is Exploding Higher Monday
Unicycive Therapeutics Inc (NASDAQ: UNCY) shares are exploding higher Monday after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch Renazorb, a phosphate binder that potently controls phosphate with just